Global Immune Technologies Finalizes Solar Deal With Germans
Opt-In to receive our popular Newsletter by email. We will send you the latest Industry News, Research and Expert Opinion. Investors and Job Seekers will enjoy our daily updates of the Solar Thermal Industry.
The Fastest Growing Solar Market World Wide!
For the Homeowners we include regular updates of the latest solar heating and cooling products and services. Opt-In today, you can cancel at anytime (but no-one does!)
Opt-in to the Newsletter by Email
GLOBAL IMMUNE TECHNOLOGIES ISSUES SHARES
WINDISCHLEUBE, Germany. – The Board of Directors of Global Immune Technologies, Inc. (OTB QB: GIMU) announced that the deal originally announced on December 22, 2010 has been finalized with Mid Atlantic Capital Associates SL of Mallorca, Spain and Institute of Applied Technology of Germany previously announced. The Joint Venture agreed to has also been closed and the entity RenOnuG has been formed as a German company. The details of the JV were disclosed in our 8K filing of February 22nd.
On 15 February 2011 the Institute of Applied Technology was issued shares of common stock in the amount of 92,000,000 shares being approximately 80.08% of the then issued shares of common stock outstanding. Additionally 1,000,000 shares were paid as the fee for the deal to the seller, Mid Atlantic Capital Associates SL and a finder’s fee of 5,694,508 shares were paid equalling less than 5% of the then issued and outstanding common stock. The Registrant now has 114,890,153 shares of common stock issued and outstanding with no change in the float estimated at approximately 11,000,000 shares.
An 8K will be filed shortly.
Further information can be obtained by phoning Jeffrey R. Bruhjell +1 406 558 4947
Tags: german solar investments, investment news, solar stocks in germany, solar technologies
Short URL: https://www.solarthermalmagazine.com/?p=7244
